ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 171 filers reported holding ANIKA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $276,000 | -56.5% | 7,800 | -53.6% | 0.00% | -57.1% |
Q2 2020 | $634,000 | +20.5% | 16,800 | -7.7% | 0.01% | 0.0% |
Q1 2020 | $526,000 | -30.5% | 18,200 | +24.7% | 0.01% | -12.5% |
Q4 2019 | $757,000 | -4.9% | 14,600 | +0.7% | 0.01% | -11.1% |
Q3 2019 | $796,000 | +88.6% | 14,500 | +39.4% | 0.01% | +80.0% |
Q2 2019 | $422,000 | +34.4% | 10,400 | 0.0% | 0.01% | +25.0% |
Q1 2019 | $314,000 | -11.0% | 10,400 | -1.0% | 0.00% | -20.0% |
Q4 2018 | $353,000 | -33.0% | 10,500 | -16.0% | 0.01% | -16.7% |
Q3 2018 | $527,000 | +31.8% | 12,500 | 0.0% | 0.01% | +20.0% |
Q2 2018 | $400,000 | -35.7% | 12,500 | 0.0% | 0.01% | -37.5% |
Q1 2018 | $622,000 | -40.2% | 12,500 | -35.2% | 0.01% | -33.3% |
Q4 2017 | $1,040,000 | -14.6% | 19,300 | -8.1% | 0.01% | -20.0% |
Q3 2017 | $1,218,000 | +4.2% | 21,000 | -11.4% | 0.02% | 0.0% |
Q2 2017 | $1,169,000 | +7.6% | 23,700 | -5.2% | 0.02% | +7.1% |
Q1 2017 | $1,086,000 | +57.4% | 25,000 | +77.3% | 0.01% | +40.0% |
Q4 2016 | $690,000 | +85.0% | 14,100 | +80.8% | 0.01% | +100.0% |
Q3 2016 | $373,000 | -66.1% | 7,800 | -70.9% | 0.01% | -76.2% |
Q1 2014 | $1,101,000 | +344.0% | 26,800 | +312.3% | 0.02% | +320.0% |
Q4 2013 | $248,000 | – | 6,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |